Julia Canestraro

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Immune Checkpoint Inhibitor-Associated Optic Neuritis”.

Immune Checkpoint Inhibitor-Associated Optic Neuritis

Ophthalmology(2020)10.1016/j.ophtha.2020.05.003

N/A

0DataRank · unranked

61 citations

Korey Jaben, Bianca Santomasso, Julia Canestraro, David H. Abramson, Paul B. Chapman +3 more

Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors

American Journal of Ophthalmology Case Reports(2020)10.1016/j.ajoc.2020.100799

N/A

0DataRank · unranked

16 citations

Korey Jaben, Jedd D. Wolchok, David H. Abramson, Jasmine H. Francis, Julia Canestraro

Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy

Ophthalmology Retina(2021)10.1016/j.oret.2021.06.001

N/A

0DataRank · unranked

14 citations

Julia Canestraro, Dianna Haggag-Lindgren, James J. Harding, Eli L. Diamond, Alexander Drilon +5 more

Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis)

American Journal of Ophthalmology Case Reports(2021)10.1016/j.ajoc.2021.101125

N/A

0DataRank · unranked

3 citations

Anna Do, Seth D. Potash, Joseph F. Panarelli, Meghan Berkenstock, David H. Abramson +2 more

Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?

Ocular Oncology and Pathology(2023)10.1159/000529127

N/A

0DataRank · unranked

3 citations

William Foulsham, Julia Canestraro, James J. Harding, Eli L. Diamond, David H. Abramson +2 more

Ocular side effects of anticancer agents used in the treatment of gynecologic cancers

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.003

N/A

0DataRank · unranked

3 citations

Sophie Broderick, Jasmine H. Francis, Roisin E. O’Cearbhaill, Julia Canestraro, Fionnuala Crowley

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100792

N/A

0DataRank · unranked

3 citations

Rose Parisi, Guilherme Harada, Andrea P. Moy, George Dranitsaris, Jasmine H. Francis +7 more